Concurrent Autoimmune and Endocrine Dysregulation in Polycystic Ovary Syndrome
July 2025
in “
Middle East Fertility Society Journal
”
Studysummary This study found that women with PCOS had significantly higher levels of several autoantibodies compared to healthy controls, suggesting a potential autoimmune component to PCOS that might aid in better disease characterization and personalized management. Our plain-language summary of this paper — not a Tressless recommendation.
This study involving 178 participants (100 with PCOS and 78 controls) reveals that women with polycystic ovary syndrome (PCOS) have higher levels of autoantibodies, such as anti-thyroid peroxidase (anti-TPO), anti-glutamic acid decarboxylase (anti-GAD), and anti-thrombopoietin (anti-THPO), indicating a potential autoimmune component in PCOS pathogenesis. Additionally, PCOS patients exhibit a distinct endocrine profile with elevated LH/FSH ratios, hyperandrogenism, and increased AMH levels, alongside higher prolactin and thyroid hormone levels. The study suggests that autoimmune dysregulation is linked with the metabolic and hormonal abnormalities in PCOS, advocating for the inclusion of thyroid and other autoantibody screenings in PCOS evaluations to identify individuals at risk for concurrent autoimmune disorders.
